@Article{,
AUTHOR = {Alon Lazarovich, Thenappan Chandrasekar, Alina Basnet, Gennady Bratslavsky, Hanan Goldberg},
TITLE = {Does a prior cancer diagnosis impact PSA  testing? Results from the National Health  Interview Survey},
JOURNAL = {Canadian Journal of Urology},
VOLUME = {30},
YEAR = {2023},
NUMBER = {3},
PAGES = {11551--11557},
URL = {http://www.techscience.com/CJU/v30n3/59708},
ISSN = {1488-5581},
ABSTRACT = {<b>Introduction:</b> Prostate-specific antigen (PSA) testing remains a controversial issue. However, most urological guidelines recommend PSA testing in men aged 55-69 through a shared decision-making process with the patient. The impact of prior cancer diagnosis on PSA testing is not well-known. To compare PSA testing in men aged 55-69 years with and without a history of cancer (excluding prostate cancer patients).<br/>
<b>Materials and methods:</b> Utilizing the National Health Interview Survey (NHIS), a retrospective cross-sectional study during the year 2018 was carried out. Multivariable logistic regression analysis was implemented to demonstrate potential associations with PSA testing and assess the association of cancer history.<br/>
<b>Results:</b> A total of 2,892 men aged 55-69 years from the NHIS survey who met the inclusion criteria were analyzed. A total of 308 (10.7%) men had a history of cancer (non-prostate). Men with a cancer history had a higher number of PSA tests and more recent testing than men with no previous cancer history. On multivariable analysis, men who were previously diagnosed with cancer had a higher likelihood of undergoing PSA testing compared to men with no history of cancer (OR: 1.87, 95% CI 1.39-2.52, p < 0.0001).<br/>
<b>Conclusions:</b> Our data suggest that men aged 55-69 with a history of cancer are more likely to undergo PSA testing than men with no cancer history.},
DOI = {}
}